Clinical Trial Update: A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) [Phase 3]

View source ↗

Summary

Phase 3 trial update of peginterferon alfa-2a in combination with ribavirin for chronic hepatitis C patients with compensated liver cirrhosis; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Cirrhosis

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Liver Cirrhosis, Chronic Hepatitis C | Phase 3 | Status: COMPLETED